Good Morning, Traders!…👋

It’s Wednesday, August 6, 2025. Today's futures indicate a cautiously optimistic start to the trading day, following a mixed performance in global markets. Investors are likely to be watching for new economic data and corporate earnings reports to gauge market direction.

Earnings Watch

Earnings hit today from McDonald’s $MCD, Walt Disney $DIS, Uber Technologies $UBER, and Shopify $SHOP before open, plus AppLovin $APP, DoorDash $DASH, and Airbnb $ABNB after close.

Analysts expect MCD at $2.66 EPS with global sales focus, DIS at $1.20 EPS on streaming and parks recovery, UBER at $0.37 EPS amid ride-hailing growth, SHOP at $0.20 EPS with e-commerce strength, APP at $0.94 EPS on ad tech demand, DASH at $0.09 EPS with delivery trends, and ABNB at $0.92 EPS on travel demand.

Happening Today

✓ 10:30 AM ET – Oil Inventories

✓ 01:00 PM ET – 10-Year Note Auction

✓ 04:10 PM ET – FOMC Member Daly Speaks

SECTOR SNAPSHOT

On the last trading day, market sectors were mixed, with Materials, Real Estate, and Energy posting gains. However, a number of key sectors, including Information Technology, Communication Services, and Utilities, experienced declines, suggesting a rotation in investor focus amidst broader market uncertainty.

PreMarket Unusual Volume Stocks

Here's a quick rundown of today's pre-market high-volume stocks:

📈 Ontrak, Inc. (OTRK) is up +14.46% at $0.3860 with significant volume, despite a report last week stating the company has ceased all operations and terminated employees, making this a highly speculative move.

📈 Xcel Brands, Inc (XELB) is gaining +23.89% at $1.13 with high volume, following its recent pricing of a $2.6 million public offering and a concurrent private placement.

📈 Myriad Genetics, Inc. (MYGN) is up +31.27% to $3.87 with notable volume, surging after yesterday's Q2 2025 earnings report that beat revenue estimates, raised its full-year revenue guidance, and announced a new $200 million credit facility.

📈 Safe & Green Holdings Corp. (SGBX) sees a +5.38% rise to $0.1933 with increased volume, following yesterday's announcement of a non-binding letter of intent to acquire Rock Springs Energy Group for approximately $35 million.

📈 CryoPort, Inc. (CYRX) is up +24.63% at $6.74 with notable volume, as investors react positively to yesterday's news of its upcoming Q2 earnings report, and a recent analyst upgrade to "Overweight" with a $13 price target.

Premarket Picks

Astera Labs, Inc. (ALAB) is trading at $158.00, up 16.57% in pre-market. The surge follows the company’s Q2 FY2025 financial results, reporting record quarterly revenue of $191.9 million — a 20% increase quarter-over-quarter and 150% year-over-year. Operating cash flow also hit a record $135.4 million.

RingCentral, Inc. (RNG) rose 17.65% pre-market to $27.79. This jump comes after NiCE announced a renewed multi-year collaboration with RingCentral to market and sell the RingCentral Contact Center™, powered by NiCE CXone Mpower, strengthening their long-term partnership.

Myriad Genetics, Inc. (MYGN) surged 31.78% to $5.10 before the market opened. The company reported Q2 results and raised its 2025 revenue guidance to $818–$828 million, up from the previous $807–$823 million forecast.

Cryoport, Inc. (CYRX) climbed 29.67% pre-market to $8.74 after reporting Q2 2025 revenue of $45.5 million, marking a 14% increase year-over-year.

Below is a complete list of hot stocks in pre-market today:

Top Upgrades:

1. TopBuild Corp. (BLD)

Analyst Firm: Seaport Research

Upgraded: Neutral to Buy

Price Target: $450

Yesterday's Close: $408.08

Seaport Research analyst Kenneth Zener raised his rating on TopBuild from Neutral to Buy and set a new price target of $450. Analysts have set a high price target of $466.00 for TopBuild Corp., with a median estimate of $421.50 and a low of $320.00. The average target price stands at $416.00. TopBuild specializes in installing and distributing insulation and building materials.

2. Halozyme Therapeutics, Inc. (HALO)

Analyst Firm: Morgan Stanley

Upgraded: Equal Weight to Overweight

Price Target: $75

Yesterday's Close: $60.81

Morgan Stanley boosted its rating on Halozyme from Equal Weight to Overweight, increasing the price target from $62 to $75. Halozyme Therapeutics has a high stock price target of $91.00, a median of $72.00, and a low estimate of $51.00, with an average target price of $69.22. The company develops and sells biopharmaceutical enzymes and medical devices.

3. Cryoport, Inc. (CYRX)

Analyst Firm: KeyBanc

Upgraded: Sector Weight to Overweight

Price Target: $15

Yesterday's Close: $6.74

KeyBanc upgraded Cryoport from Sector Weight to Overweight, assigning a price target of $15. For Cryoport, analysts project a high price target of $15.00, a median of $11.00, and a low of $8.00. The average target price is $11.80. Cryoport specializes in delivering cold-chain logistics solutions for health and medicine.

Maeve Grace
Editor In Chief
Premium Stock Alerts

Important: This newsletter does not provide investment advice. The stocks mentioned should not be taken as recommendations. Your investments are solely your decisions.

Disclosure: I hold no positions in any companies mentioned, either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I have no business relationship with any company whose stock is mentioned in this article.